MX2019011173A - Compuesto que contiene silicio para la resistencia a la infeccion por el virus de la hepatitis c. - Google Patents
Compuesto que contiene silicio para la resistencia a la infeccion por el virus de la hepatitis c.Info
- Publication number
- MX2019011173A MX2019011173A MX2019011173A MX2019011173A MX2019011173A MX 2019011173 A MX2019011173 A MX 2019011173A MX 2019011173 A MX2019011173 A MX 2019011173A MX 2019011173 A MX2019011173 A MX 2019011173A MX 2019011173 A MX2019011173 A MX 2019011173A
- Authority
- MX
- Mexico
- Prior art keywords
- hepatitis
- virus infection
- silicon
- resistance
- containing compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0816—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Abstract
La presente invención proporciona un compuesto que contiene silicio para la resistencia a la infección por virus de la hepatitis c y, en particular, proporciona un compuesto representado por la fórmula I, o una sal farmacéuticamente aceptable, o un tautómero, o un estereoisómero, o un compuesto deuterado del mismo y una mezcla entre ellos, un proceso para la preparación de este, y una composición farmacéutica que comprende el mismo. La presente solicitud también proporciona un uso del compuesto, o una sal farmacéuticamente aceptable, o un tautómero, o un estereoisómero, o un compuesto deuterado del mismo y una mezcla entre ellos, y una composición farmacéutica que comprende el mismo en el tratamiento de la infección por virus de la hepatitis c.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710172925 | 2017-03-22 | ||
| CN201710845367 | 2017-09-19 | ||
| PCT/CN2018/079965 WO2018171660A1 (zh) | 2017-03-22 | 2018-03-22 | 用于抗丙型肝炎病毒感染的含硅化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019011173A true MX2019011173A (es) | 2020-01-09 |
Family
ID=63585044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019011173A MX2019011173A (es) | 2017-03-22 | 2018-03-22 | Compuesto que contiene silicio para la resistencia a la infeccion por el virus de la hepatitis c. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10766912B2 (es) |
| EP (1) | EP3604295A4 (es) |
| JP (1) | JP2020512331A (es) |
| CN (1) | CN110382487B (es) |
| BR (1) | BR112019019724A2 (es) |
| MX (1) | MX2019011173A (es) |
| WO (1) | WO2018171660A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN101558059B (zh) | 2006-08-11 | 2014-12-03 | 百时美施贵宝公司 | 丙型肝炎病毒抑制剂 |
| CN103819459B (zh) * | 2009-06-11 | 2017-05-17 | 艾伯维巴哈马有限公司 | 抗病毒化合物 |
| US8937150B2 (en) * | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| EA201290882A1 (ru) * | 2010-03-09 | 2013-04-30 | Мерк Шарп Энд Домэ Корп. | Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний |
| WO2013054275A1 (en) * | 2011-10-11 | 2013-04-18 | Council Of Scientific & Industrial Research | Sila analogs of oxazolidinone derivatives and synthesis thereof |
| US8927749B2 (en) * | 2013-03-07 | 2015-01-06 | Universal Display Corporation | Organic electroluminescent materials and devices |
| WO2016095814A1 (en) * | 2014-12-16 | 2016-06-23 | Sunshine Lake Pharma Co., Ltd. | Bridged ring compounds as hepatitis c virus inhibitors and preparation thereof |
-
2018
- 2018-03-22 MX MX2019011173A patent/MX2019011173A/es unknown
- 2018-03-22 BR BR112019019724A patent/BR112019019724A2/pt not_active Application Discontinuation
- 2018-03-22 CN CN201880015765.9A patent/CN110382487B/zh active Active
- 2018-03-22 WO PCT/CN2018/079965 patent/WO2018171660A1/zh unknown
- 2018-03-22 JP JP2019552128A patent/JP2020512331A/ja active Pending
- 2018-03-22 US US16/494,604 patent/US10766912B2/en active Active
- 2018-03-22 EP EP18771081.9A patent/EP3604295A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020512331A (ja) | 2020-04-23 |
| US20200017532A1 (en) | 2020-01-16 |
| WO2018171660A1 (zh) | 2018-09-27 |
| BR112019019724A2 (pt) | 2020-04-14 |
| EP3604295A4 (en) | 2020-12-16 |
| US10766912B2 (en) | 2020-09-08 |
| EP3604295A1 (en) | 2020-02-05 |
| CN110382487A (zh) | 2019-10-25 |
| CN110382487B (zh) | 2021-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551089A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| PH12018550201A1 (en) | Hepatitis b antiviral agents | |
| EA201890200A1 (ru) | Производные циклизированного сульфамоилариламида и их применение в качестве лекарственных препаратов для лечения гепатита b | |
| MY200608A (en) | Hiv inhibitor compounds | |
| JOP20170045B1 (ar) | مركبات بيريدون رباعية الحلقة كمضادات فيروسية | |
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| SG10201811384TA (en) | Mnk inhibitors and methods related thereto | |
| EA201791872A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| MX2017007814A (es) | Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| BR112017022544A2 (pt) | ?composto, composição, e, método para tratamento de infecção por hiv?. | |
| NZ631726A (en) | Therapeutic compounds for the treatment of viral infections | |
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| AU2018253590A1 (en) | Imidazopyridazine compounds | |
| TN2015000293A1 (en) | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
| PH12017502009A1 (en) | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection | |
| MX2021015056A (es) | Compuesto de pirrolopirimidina y uso del mismo. | |
| MX2019013815A (es) | Inhibidor de antigenos de superficie del virus de la hepatitis b. | |
| CR20220216A (es) | Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1 | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| TN2017000485A1 (en) | Tricyclic compounds and their use as phosphodiesterase inhibitors | |
| EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
| PH12017501687A1 (en) | Inhibitors of hepatitis c virus polymerase | |
| PH12020551117A1 (en) | Compositions for preventing or treating uveitis | |
| MX2019011173A (es) | Compuesto que contiene silicio para la resistencia a la infeccion por el virus de la hepatitis c. | |
| PH12020550549A1 (en) | Compositions for preventing or treating lupus |